Allogeneic Hematopoietic Cell Transplantation for Relapsed or Refractory Mantle Cell Lymphoma: Real‐World Outcomes, Late Relapse Patterns, and Clinical Utility in the Chimeric Antigen Receptor T‐Cell Era

ABSTRACT Background Allogeneic hematopoietic cell transplantation (alloHCT) remains a curative option for relapsed or refractory (r/r) mantle cell lymphoma (MCL), although its role has shifted in the era of Bruton tyrosine kinase inhibition (BTKi) and chimeric antigen receptor T‐cell (CAR‐T) therapy...

Descrición completa

Detalles Bibliográficos

Principais autores:	Enver Aydilek, Paolo Mazzeo, Justin Hasenkamp, Markus Maulhardt, Tobias Tix, Evgenii Shumilov, Gerald Wulf
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2026-06-01
Series:	eJHaem
Assuntos:	allogeneic hematopoietic cell transplantation CAR‐T era late relapse mantle cell lymphoma relapsed or refractory disease
Acceso en liña:	https://doi.org/10.1002/jha2.70318
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!